NexPoint Life Sciences III DST

Amendment
CIK: 0002008210·Other Real Estate·DELAWARE·Filed: Jan 29, 2025
Total Offering

$30,661,253

Amount Sold

$9,865,646

Investors

41

First Sale

Jan 25, 2024

Offering Details

Type
Equity, Pooled Investment Fund
Exemptions
Rule 506(c), Section 3(c), Section 3(c)(1), Section 3(c)(5)
Entity Type
Other
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
NREA LS III Contributor, LLC
Related Person
Brian Mitts
Related Person
Matt McGraner
Related Person
NexPoint Real Estate Advisors IV, L.P.
Related Person
NREA LS III Manager, LLC
Related Person

Company

NexPoint Life Sciences III DST

300 CRESCENT COURT

DALLAS, TX, 75201

(833) 697-6246

SEC Filing

0002008210-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free